Ticker: TLRY

Tilray

Healthcare Healthcare Drug Manufacturers - Specialty & Generic
Price 3.88
Reco Sell Potential 20 Risk 85 Updated 2026-07-25

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Tilray is a healthcare company primarily focused on the production and distribution of cannabis products for medical and recreational use. Its core offerings include dried cannabis, oils, and edibles. The company operates in various segments, including medical cannabis, adult-use cannabis, and international markets. Major revenue sources stem from product sales in these segments, with a growing emphasis on expanding its global footprint.

Investment Profile

The investment profile of Tilray suggests it may be more suitable for value investors, given its current financial challenges and lack of dividends. The stock exhibits high volatility, indicating potential risks that may deter growth-focused investors. A balanced approach could be considered, but the overall outlook remains cautious due to recent performance metrics.

Fundamental metrics (experimental) Updated: 2026-07-26
EPS (TTM) — earnings per share for the last 12 months, $
-18.70
Revenue QoQ — quarter-over-quarter revenue growth
-7.1%
EPS surprise
-71.4%
20d volatility
2.0%
AI recommendation changes
Date Before After Reason
2026-05-08 Sell scenario_deterioration
2026-05-08 Sell Sell scenario_deterioration
2026-03-21 Hold Sell scenario_deterioration
Analyst forecasts
Date Analyst Action Target Price Then
2026-01-20 Roth Capital Target Lowered 20 → 10 8.935
2026-01-09 Industrial Alliance Securities Target Lowered 20 → 10 9.13
2025-12-19 Bernstein Target Raised 1 → 10 12.34
News Page 1 of 1

Nothing yet